General description
Clindamycin is a lincosamide antibiotic with activity against gram-positive cocci and many anaerobes.
INN
Clindamycin
ATC codes
Medicine type
Chemical agent
Antibiotic groups
EML status history
First added in 1991
(TRS
825)
for
Bacterial infection of unspecified site
Added in 2017
(TRS
1006)
for
Osteomyelitis or osteitis
Added in 2017
(TRS
1006)
for
Bacterial infection of joint
Removed in 2017
(TRS
1006)
for
Bacterial infection of unspecified site
Added in 2021
(TRS
1035)
for
Necrotising fasciitis
Wikipedia
DrugBank
Recommendations
Section
Access group antibiotics
- Parenteral > General injections > IV: 150 mg per mL (as phosphate); 600 mg per 4 mL (as phosphate); 900 mg per 6 mL (as phosphate)
- Oral > Liquid: 75 mg per 5 mL powder for oral liquid (as palmitate hydrochloride)
- Oral > Solid: 150 mg (as hydrochloride)
- Oral > Liquid: 75 mg per 5 mL (as palmitate hydrochloride)
- Oral > Solid: 150 mg (as hydrochloride) capsule
- Parenteral > General injections > unspecified: 150 mg per mL (as phosphate) injection
Indications
First choice
co-prescribed with piperacillin + tazobactam Necrotising fasciitis
Other indications